Knobbe Martens partners Jeremiah Helm and Sean Murray explored the Federal Circuit’s opinion on patent claim construction in Netflix Inc. v. DivX LLC in their latest Law360 column on the…

IRVINE, Calif., April 1, 2026 – Knobbe Martens is pleased to share that the firm and several of its partners were highlighted in Patexia’s 2026 Patent Prosecution Leaders report for…

The Credibility of Experts Is in the Province of the Jury Ari Feinstein & Kathryn M. McCarthy Neither the fact that a damages expert’s testimony could have been presented more clearly, nor…

Be Kind, Please Rewind – Is Blockbuster Still Famous for a Dilution Claim? Greg Phillips &  Eric R. Blosser The Trademark Trial and Appeal Board (“TTAB”) is currently reviewing a case…

Key Takeaway: The PTO Director’s sua sponte rehearing of Ex parte Baurin raises questions regarding the scope of Allergan v. MSN, Examiners’ role in obviousness-type double patenting rejections, and the…

Knobbe Martens Sports and Gaming Practice co-chair Jonathan Menkes was recently quoted in World Trademark Review discussing a U.S. district court decision finding that certain UGG boot designs lack protectable…

Key Takeaways Effective immediately, the USPTO will consider whether a patent challenger’s accused products or a patent owner’s products are manufactured in the United States as additional factors in the…

Key Takeaway: The USPTO has revised its design patent guidance to better reflect evolving digital interface technologies, including projections and augmented or virtual reality environments. The updated guidance provides design…

In the Law360 article “Manufacturing Factor Adds More New Twists to AIA Cases,” Knobbe Martens partner Sheila Swaroop weighed in on the U.S. Patent & Trademark Office’s latest memo regarding…

IRVINE, Calif., March 16, 2026 – A team from Knobbe Martens secured a complete defensive victory for Edwards Lifesciences in a patent dispute with Aortic Innovations involving Edwards’ lifesaving transcatheter…